Literature DB >> 27621017

Therapeutic anticoagulation in patients with traumatic brain injury.

Kazuhide Matsushima1, Kenji Inaba2, Jayun Cho2, Hussan Mohammed3, Keith Herr3, Stefan Leichtle2, Gabriel Zada4, Demetrios Demetriades2.   

Abstract

BACKGROUND: Therapeutic anticoagulation (TAC) is often required in trauma patients for various indications. However, it remains unknown whether TAC can be safely initiated in the postinjury period for patients with traumatic brain injury (TBI). The purpose of this study was to evaluate the safety of TAC in TBI patients.
MATERIALS AND METHODS: We conducted a 7-y retrospective study. All TBI patients who received TAC within 60 d postinjury were included. In addition to patient and injury characteristics, detailed information regarding TAC was collected. The primary outcome was the incidence of neurologic deterioration or progression of hemorrhagic TBI on repeat head computed tomography (CT) after initiation of TAC. Univariate and multivariate analyses were used to identify factors associated with progression of hemorrhagic TBI after TAC.
RESULTS: A total of 3355 TBI patients were identified. Of those, 72 patients (2.1%) received TAC. Median age, 59; 76.4% male; median Injury Severity Score, 19; median admission Glasgow Coma Scale, 14; and median Rotterdam score on the initial head CT, 3. Although atrial fibrillation was the most common preinjury indication for TAC, venous thromboembolism was the most common postinjury indication. The median postinjury time of initiation of TAC was 9 d. Intravenous heparin infusion was the most commonly used agent for TAC (70.8%). None of our study patients developed any signs of neurologic deterioration due to TAC. Progression of hemorrhagic TBI on repeat head CT was observed in six patients. In a multiple logistic regression model, aged ≥65 y was significantly associated with progression of hemorrhagic TBI after TAC (odds ratio, 15.2; 95% confidence interval, 1.1-212.7; P = 0.04).
CONCLUSIONS: This study shows preliminary data regarding TAC initiated in patients with TBI. Further prospective study is warranted to determine the risks and benefits of TAC in this specific group of patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Outcome; Safety; Therapeutic anticoagulation; Traumatic brain injury

Mesh:

Substances:

Year:  2016        PMID: 27621017     DOI: 10.1016/j.jss.2016.06.042

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Early bilateral pulmonary embolism in a polytrauma patient: About a case report.

Authors:  I Arhoun El Haddad; A El Mouhib; O Hattab; M Assamti; A Mojahid; H Bkiyer; S Nasri; I Skiker; El Ouafi; B Housni
Journal:  Ann Med Surg (Lond)       Date:  2022-05-30

2.  Therapeutic Dilemmas Regarding Anticoagulation: An Experience in a Patient with Nephrotic Syndrome, Pulmonary Embolism, and Traumatic Brain Injury.

Authors:  Tetsu Akimoto; Tomoyuki Yamazaki; Eiji Kusano; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2016-11-03

Review 3.  Antithrombotics in trauma: management strategies in the older patients.

Authors:  Henna Wong; Nicola Lovett; Nicola Curry; Ku Shah; Simon J Stanworth
Journal:  J Blood Med       Date:  2017-10-04

4.  Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement.

Authors:  Marion Wiegele; Herbert Schöchl; Alexander Haushofer; Martin Ortler; Johannes Leitgeb; Oskar Kwasny; Ronny Beer; Cihan Ay; Eva Schaden
Journal:  Crit Care       Date:  2019-02-22       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.